IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 256 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,732,000 | -13.2% | 389,588 | 0.0% | 0.66% | -33.3% |
| Q2 2022 | $4,301,000 | -33.7% | 389,588 | 0.0% | 0.98% | -35.9% |
| Q1 2022 | $6,487,000 | -12.8% | 389,588 | 0.0% | 1.53% | -37.4% |
| Q4 2021 | $7,437,000 | -22.6% | 389,588 | 0.0% | 2.45% | -29.8% |
| Q3 2021 | $9,607,000 | -27.0% | 389,588 | -23.0% | 3.49% | -35.4% |
| Q2 2021 | $13,163,000 | -26.5% | 505,890 | -10.6% | 5.41% | -28.3% |
| Q1 2021 | $17,916,000 | -31.8% | 565,890 | 0.0% | 7.55% | -19.6% |
| Q4 2020 | $26,257,000 | +33.6% | 565,890 | -5.2% | 9.39% | +12.8% |
| Q3 2020 | $19,650,000 | +18.5% | 596,890 | -1.2% | 8.32% | +12.6% |
| Q2 2020 | $16,577,000 | +12.7% | 603,890 | +22.9% | 7.39% | -17.1% |
| Q1 2020 | $14,710,000 | +17.1% | 491,390 | +8.3% | 8.92% | +17.2% |
| Q4 2019 | $12,564,000 | – | 453,890 | – | 7.62% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 3,876,600 | $127,618,000 | 11.48% |
| Fairmount Funds Management LLC | 596,890 | $19,650,000 | 8.32% |
| Ghost Tree Capital, LLC | 575,000 | $18,929,000 | 5.47% |
| Perceptive Advisors | 10,085,632 | $332,019,000 | 4.85% |
| Avoro Capital Advisors LLC | 9,536,039 | $313,926,000 | 4.46% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $43,224,000 | 3.88% |
| ACUTA CAPITAL PARTNERS, LLC | 315,000 | $10,370,000 | 2.82% |
| Orbimed Advisors | 6,645,100 | $218,757,000 | 2.75% |
| QVT Financial LP | 572,971 | $18,862,000 | 2.30% |
| Prosight Management, LP | 120,606 | $3,970,000 | 1.89% |